136 related articles for article (PubMed ID: 37377173)
21. ATP-citrate lyase deficiency in the mouse.
Beigneux AP; Kosinski C; Gavino B; Horton JD; Skarnes WC; Young SG
J Biol Chem; 2004 Mar; 279(10):9557-64. PubMed ID: 14662765
[TBL] [Abstract][Full Text] [Related]
22. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells.
Chu KY; Lin Y; Hendel A; Kulpa JE; Brownsey RW; Johnson JD
J Biol Chem; 2010 Oct; 285(42):32606-15. PubMed ID: 20693577
[TBL] [Abstract][Full Text] [Related]
23. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
[TBL] [Abstract][Full Text] [Related]
25. The vital role of ATP citrate lyase in chronic diseases.
Khwairakpam AD; Banik K; Girisa S; Shabnam B; Shakibaei M; Fan L; Arfuso F; Monisha J; Wang H; Mao X; Sethi G; Kunnumakkara AB
J Mol Med (Berl); 2020 Jan; 98(1):71-95. PubMed ID: 31858156
[TBL] [Abstract][Full Text] [Related]
26. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.
Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC
J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453
[TBL] [Abstract][Full Text] [Related]
27. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
28. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
29. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.
Zhang C; Liu J; Huang G; Zhao Y; Yue X; Wu H; Li J; Zhu J; Shen Z; Haffty BG; Hu W; Feng Z
Genes Dev; 2016 Sep; 30(17):1956-70. PubMed ID: 27664236
[TBL] [Abstract][Full Text] [Related]
30. Key Molecules of Fatty Acid Metabolism in Gastric Cancer.
Li C; Zhang L; Qiu Z; Deng W; Wang W
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625633
[TBL] [Abstract][Full Text] [Related]
31. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street.
White PJ; McGarrah RW; Herman MA; Bain JR; Shah SH; Newgard CB
Mol Metab; 2021 Oct; 52():101261. PubMed ID: 34044180
[TBL] [Abstract][Full Text] [Related]
32. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
[TBL] [Abstract][Full Text] [Related]
33. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38.
Zhou Y; Bollu LR; Tozzi F; Ye X; Bhattacharya R; Gao G; Dupre E; Xia L; Lu J; Fan F; Bellister S; Ellis LM; Weihua Z
Mol Cancer Ther; 2013 Dec; 12(12):2782-91. PubMed ID: 24132143
[TBL] [Abstract][Full Text] [Related]
34. miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARγ in gastric cancer.
Cheng Y; Jia B; Wang Y; Wan S
Oncol Rep; 2017 Nov; 38(5):3220-3226. PubMed ID: 28901466
[TBL] [Abstract][Full Text] [Related]
35. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
[TBL] [Abstract][Full Text] [Related]
36. ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection.
Vysochan A; Sengupta A; Weljie AM; Alwine JC; Yu Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1528-E1535. PubMed ID: 28167750
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of ATP citrate lyase (ACLY) protects airway epithelia from PM
Fu Y; Lu R; Cui J; Sun H; Yang H; Meng Q; Wu S; Aschner M; Li X; Chen R
Ecotoxicol Environ Saf; 2019 Jan; 167():309-316. PubMed ID: 30343145
[TBL] [Abstract][Full Text] [Related]
38. Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.
Lucenay KS; Doostan I; Karakas C; Bui T; Ding Z; Mills GB; Hunt KK; Keyomarsi K
Cancer Res; 2016 Apr; 76(8):2406-18. PubMed ID: 26928812
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
40. ER resident protein 44 promotes malignant phenotype in nasopharyngeal carcinoma through the interaction with ATP citrate lyase.
Tian H; Shi S; You B; Zhang Q; Gu M; You Y
J Transl Med; 2021 Feb; 19(1):77. PubMed ID: 33593371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
